Abstract
In order to increase process efficiency, many pharmaceutical and biotechnology companies have introduced disposable bag technology over the last 10 years. Because this technology also greatly reduces the risk of cross-contamination, disposable bags are preferred in applications in which an absolute or improved process safety is a necessity, namely the production of functional tissue for implantation (tissue engineering), the production of human cells for the treatment of cancer and immune system diseases (cellular therapy), the production of viruses for gene therapies, the production of therapeutic proteins, and veterinary as well as human vaccines. Bioreactors with a pre-sterile cultivation bag made of plastic material are currently used in both development and manufacturing processes primarily operating with animal and human cells at small- and middle-volume scale. Due to their scalability, hydrodynamic expertise and the convincing results of oxygen transport efficiency studies, wave-mixed bioreactors are the most used, together with stirred bag bioreactors and static bags, which have the longest tradition. Starting with a general overview of disposable bag bioreactors and their main applications, the following paper summarizes the working principles and engineering aspects of bag bioreactors suitable for cell expansion, formation of functional tissue and production of therapeutic agents. Furthermore, results from selected cultivation studies are presented and discussed.
Abbreviations
- AAV:
-
Adeno-associated virus
- ACD:
-
Aseptic connection device
- AD:
-
Aujeszky’s disease
- ADV:
-
Aujeszky’s disease virus
- B cells:
-
Lymphocytes which produce antibodies against soluble antigens
- BEV:
-
Baculovirus expression vector
- BHK cells:
-
Baby hamster kidney cells
- BHV:
-
Bovine herpes virus
- CHO cells:
-
Chinese hamster ovary cells
- CV:
-
Culture volume
- dhfr− :
-
Dihydrofolate reductase deficient
- E. coli:
-
Escherichia coli
- E-FL cells:
-
Embryogenic feline lung fibroblast cells
- FDA:
-
Food and Drug Administration
- G. max:
-
Glycine max
- GMP:
-
Good Manufacturing Practice
- GS-NS0:
-
Glutamine synthethase deficient mouse cell line
- H. muticus:
-
Hyoscyamus muticus
- H. procumbens:
-
Harpagophytum procumbens
- HEK cells:
-
Human embryogenic kidney cells
- HSC:
-
Haematopoietic stem cells
- IgG:
-
Immunoglobulin
- IL-2:
-
Recombinant interleukin-2
- ISO:
-
International Organization for Standardization
- kLa:
-
Gas-liquid mass transfer coefficient
- M:
-
Motor
- M. domesticus:
-
Malus domesticus
- mAb:
-
Monoclonal antibody
- MDBK cells:
-
Madin-Darby bovine kidney cells
- MDCK cells:
-
Madin-Darby canine kidney cells
- MEV:
-
Mink enteritis virus
- MOI:
-
Multiplicity of infection or optimal ratio of virus particles per cell
- N. tabacum:
-
Nicotiana tabacum
- NK cells:
-
Natural killer cells
- NS0 cells:
-
Mouse myeloma cells
- P. ginseng:
-
Panax ginseng
- P. pastoris:
-
Pichia pastoris
- pDNA:
-
Plasmid DNA
- PEI:
-
Polyethyleneimine
- PER.C6™ cells:
-
Human embryogenic retinoblast cells
- PGA:
-
Polyglycolic acid
- PLA:
-
Polylactic acid
- P/V:
-
Power input per volume
- r:
-
Recombinant
- Re:
-
Reynolds number
- rpm:
-
Revolution per minute
- RV:
-
Rabies virus
- S. cerevisiae:
-
Saccharomyces cerevisiae
- SEAP:
-
Secreted alkaline phosphatase
- SeMet:
-
Selenomethionine
- Sf:
-
Spodoptera frugiperda
- T. baccata:
-
Taxus baccata
- T cells:
-
Thymus cells, belonging to the group of lymphocytes
- TCID50 :
-
Tissue culture infectious dose
- TIB:
-
Temporary immersion bioreactor
- Tn5 cells:
-
Cells from Trichoplusia ni (insect cells, also called High Five® cells)
- TOI:
-
Optimal density of cells at infection
- tu:
-
Transducing units
- USP:
-
United States Pharmacopeial Convention
- V. vinifera:
-
Vitis vinifera
- Vero cells:
-
Kidney epithelial cells from African green monkey
- VLPs:
-
Virus-like particles
- VM:
-
Vibromixer
- vvm:
-
Volume per volume per minute
- WIM:
-
Wave-induced motion
- 3D:
-
Three-dimensional
References
DePalma A (2006) GEN 26:60
Morrow KJ (2007) GEN 28:37
Flanagan N (2007) GEN 27:38
Eibl R, Eibl D (2006) Disposable bioreactors for pharmaceutical research and manufacturing. In: Proceedings of 2nd international conference on bioreactor technology in cell, tissue culture and biomedical applications. Saariselkä, Finland
Eibl R, Eibl D (2007) ProcessPharmaTEC 4:14
Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual, 2nd edn. Cold Spring Harbor Laboratory, New York
Stang BV, Wood PA, Reddington JJ, Reddington GM, Heidel JR (1997) Monoclonal antibody production in gas-permeable bags using serum-free media. Monoclonal antibody workshop, Baltimore, California
Daley LP, Gagliardo LF, Duffy MS, Smith MC, Appleton JA (2005) Clin Diagn Lab Immunol 12:380
Purdy MH, Hogan CJ, Hami L, McNiece I, Franklin W, Jones RB, Bearman SI, Berenson RI, Cagnoni BI, Heimfeld S, Shpall EJ (1995) J Hematother 4:515
Robinet E, Certoux JM, Ferrand C, Maples P, Hardwick A, Cahn JY, Reynolds CW, Jacob W, Hervé P, Tiberghien P (1998) J Hematother 7:205
Andrews RG, Briddell RA, Hill R, Gough M, McNiece IK (1999) Stem Cells 17:210
CorCell Inc (2003) Information sheet: umbilical cord blood
Mu LJ, Gaudernack G, Saeboe-Larssen S, Hammerstad H, Tierens A, Kvalheim G (2003) Scand J Immunol 58:578
Mu LJ, Lazarova P, Gaudernack G, Saeboe-Larssen S, Kvalheim G (2004) Int J Immunopathol Pharmacol 17:255
Safinia L, Panoskaltsis N, Mantalaris A (2005) Haematopoietic culture systems. In: Chaudhuri JB, Al-Rubeai M (eds) Bioreactors for tissue engineering. Springer, Dordrecht, p 309
Halberstadt, CR, Hardin R, Bezverkov K, Snyder D, Allen L, Landeen L (1994) Biotechnol Bioeng 43:740
Purdue, GF, Hunt JL, Still JM, Law EJ, Herndon DN, Goldfarb IW, Schiller WR, Hansbrough JF, Hickerson WL, Himel HN, Kealey GP, Twomey J, Missavage AE, Solem LD, Davis M, Totoritis M, Gentzkow GD (1997) J Burn Care Rehab 18:52
Ratcliffe A, Niklason L (2002) Ann NY Acad Sci 961:210
Ducos JP, Lambot C, Pétiard V (2007) Int J Dev Biol 1:1
Ducos JP, Chantanumat P, Vuong P, Lambot C, Pètiard V (2007) Acta Hort ISHS, 764: 33
Card, C, Smith T (2006) Application report draft – SUB050601
Card C (2007) Large scale, animal free production of human monoclonal antibody using PERC.6™ cells in a disposable, stirred-tank bioreactor. Poster presented in 20th ESACT meeting 2007, Dresden, Germany
Zijlstra, G (2007) Scale-up of a PER.C6® fed-batch process in 50 and 250 L Hyclone single use bioreactors compared to 50 and 250 L stainless steel bioreactors. Poster presented in 20th ESACT meeting 2007, Dresden, Germany
Thermo Fisher Scientific (2007) Application note:AN003 Rev 1
Brecht R (2007) Disposable bioreactor technologies: challenges and trends in cGMP manufacturing. BioProduction 2007, Berlin, Germany
Ozturk SS (2007) Comparison of product quality: disposable and stainless steel bioreactor. BioProduction 2007, Berlin, Germany
Galliher P (2007) Case study: scale up to a 1,000 L perfusion in a disposable stirred tank bioreactor. BioProduction 2007, Berlin, Germany
Castillo J, Vanhamel S (2007) GEN 27:40
Zambaux JP (2007) How synergy answers the biotech industry needs. BioProduction 2007, Berlin, Germany
Collignon F, Gelbras V, Havelange N, Drugmand JC, Debras F, Mathieu E, Halloin V, Castillo J (2007) CHO cell cultivation and antibody production in a new disposable bioreactor based on magnetic driven centrifugal pump. Available at http://www.artelis.be. Accessed 20 October 2007
Zurich University of Applied Sciences, Department for Life Sciences and Facility Management, IBT, Cell cultivation techniques and biochemical engineering (2006–2007) Protocols of experiments, unpublished
Werner S, Nägeli M (2007) BioTec 3:22
Hallmann S, Bertelsen HP, Scheffler U, Luttmann R (2007) Einsatz von Massflow-Controllern zur Steuerung von Bioreaktionsprozessen. Poster presented in Biotechnica 2007 Hannover, Germany
Mikola M, Seto J, Amanullah, A (2007) Bioprocess Biosyst Eng 30:231
Laderman K, Quezada V, Dunphy N, Anderson J, Derecho J, McMahom R, Hsu D, Couture L (2007) DNA production in the Wave Bioreactor under cGMP conditions. Available at http://www.wavebiotech.com/pdfs/press/pDNA_Poster_COH2007.pfd. Accessed 6 November 2007
Eibl R, Eibl D (2002) Bioreactors for plant cell and tissue cultures. In: Oksman-Caldentey KM, Barz WH (eds) Plant biotechnology and transgenic plants. Marcel Dekker, New York, p 163
Palazón J, Mallol A, Eibl R, Lettenbauer C, Cusidó RM Piñol MT (2003) Planta Med 69: 344
Bentebibel S, Moyano E, Palazón J, Cusidó RM, Bonfill M, Eibl R, Piñol MT (2005) Biotechnol Bioeng 89:647
Girard LS, Fabis MJ, Bastin M, Courtois D, Pétiard V, Koprowski H (2006) Biochem Biophys Res Commun 345:602
Kilani J, Lebeaut JM (2006) Appl Microbiol Biotechnol 74:324
Eibl R, Eibl D (2006) Design and use of the Wave Bioreactor for plant cell culture. In: Dutta Gupta S, Ibaraki Y (eds) Plant tissue culture engineering, series: focus on biotechnology, vol 6. Springer, Dordrecht, p 203
Terrier B, Courtois D, Hénault N, Cuvier A, Bastin M, Aknin A, Dubreuil J, Pétiard V (2006) Biotechnol Bioeng 96:914
Eibl R, Eibl D (2008) Phytochem Rev, 7:593
Cuperus S, Eibl R, Hühn T, Amado R (2007) BioForum Eur 6:2
Bonfill M, Bentebibel S, Moyano E, Palazón J, Cusidó RM, Eibl R, Piñol MT (2007) Biol Plant 51:647
Amanullah A, Burden E, Jug-Dujakovic M, Mikola M, Pearre C, Herber W (2004) Development of a large-scale cell bank in cryobags for the production of biologics. Available at http://www.wavebiotech.com/pdfs/literature/Merck_Cancun-2004.pfd. Accessed 4 November 2007
CeLLution Biotech BV (2007) Mass transfer in the CELL-tainer® disposable bioreactor. Available at http://www.cellutionbiotech.com. Accessed 20 October 2007
CeLLution Biotech BV (2007) Cultivation of PER.C6®-cells in the CELL-tainer® disposable bioreactor. Available at www.cellutionbiotech.com. Accessed 20 October 2007
CeLLution Biotech BV (2007) Cultivation of CHO-cells in the CELL-tainer® disposable bioreactor. Available at www.cellutionbiotech.com. Accessed 20 October 2007
Cronin CN, Lim KB, Rogers J (2007) Protein Sci 16:2023
DÀquino R (2006) Chem Eng Prog 102:8
Fries, S, Glazomitsky K, Woods A, Forrest G, Hsu A, Olewinski R, Robinson D, Chartrain M (2005) BioProcess Int 3:36
Genzel Y, Behrendt I, Koenig S, Sann H, Reichl U (2004) Vaccine 22:2202
Genzel Y, Olmer RM, Schaefer B, Reichl U (2006) Vaccine 24:6074
Haldankar R, Li D, Saremi Z, Baikalov C, Deshpande R (2006) Bioreactors Mol Biotechnol 34:191
Houtzager E, van der Linden R, de Roo G, Huurman S, Priem P, Sijmons C (2005) BioProcess Int 3:60
Hundt B, Best C, Schlawin N, Kassner H, Genzel Y, Reichl U (2007) Vaccine 25:3987
Knevelman C, Hearle DC, Osman JJ, Khan M, Dean M, Smith M, Aiyedebinu Cheung K (2002) Characterization and operation of a disposable bioreactor as a replacement for conventional steam-in-place inoculum bioreactors for mammalian cell culture processes. Poster presented in 224th national meeting of the american chemical society, Boston, MA. American Chemical Society, Washington DC, BIOT 210
Matthews T, Wolk B (2005) The use of disposable technologies in antibody manufac-turing processes. Available at http://www.wavebiotech.com/pdfs/literature/IBCDisposables_2005.pdf. Accessed 4 November 2007
Negrete A, Kotin RM (2007) J Virol 145:155
Ohashi R, Singh V, Hammel JF (2001) Perfusion cell culture in disposable bioreactors. In: 17th ESACT meeting 2001. Tylösand, Sweden
Pierce LN and Sabraham PW (2004) Bioprocess J 3:51
Rios M (2006) Pharma Tech 4:1
Schlaeppi JM, Henke M, Mahnke M, Hartmann S, Schmitz R, Pouliquen Y, Kerins B, Weber E, Kolbinger F, Kocher HP (2006) Protein Expres Purif 50:185
Singh V (1999) Cytotechnol 30:149
Slivac I, Srček VG, Radoševic K, Kmetič I, Kniewald Z (2006) J Biosci 3:363
Tang YJ, Ohashi R, Hamel JP (2007) Biotechnol Prog 23:255
Weber W, Weber E, Geisse S, Memmert K (2002) Cytotechnol 38:77
Weber W, Bacchus W, Daoud-El Baba M, Fussenegger M (2007) Nucleic Acids Res35:e116
Weber W, Stelling J, Rimann M, Keller B, Daoud-El Baba M, Weber CC, Aubel D, Fussenegger M (2007) PNAS 104:2643
Zijlstra G, Oosterhuis N (2007) Cultivation of PERC.6®cells in the novel CELL-tainer™ high-performance disposable bioreactor. Poster presented in 20th ESACT meeting 2007, Dresden, Germany
Hami LS, Chana H, Yuan V, Craig S (2003) BioProc J 2:23
Hamis LS, Green C, Leshinsky N, Markham E, Miller K, Craig S (2004) Cytotherapy 6:554
Levine B (2007) Making waves in cell therapy: the Wave Bioreactor for the generation of adherent and non-adherent cells for clinical use. Available at http://www.wavebiotech.com/pdf/literature/ISCT_2007_Levine_Final.pdf. Accessed 4 November 2007
Curtis WR (2004) United States Patent, 6,709,862 B2
Ziv M, Ronen G, Raviv M (1998) Dev Biol Plant 34:152
Harrell RC, Bienek M, Hood CF, Munilla R, Cantliffe DY (1994) Plant Cell Tissue Org Cult 39:171
Fukui H, Tanaka M (1995) Plant Cell Tissue Org Cult 41:17
Escalona M, Lorenzo JC, Gonzalez BL, Daquinta M, Gonzalez JL, Desjardine Y, Borroto CG (1999) Plant Cell Rep 18:743
Taylor, I. (2007) The CellMaker Plus™ single-use bioreactor: a new bioreactor capable of culturing bacteria, yeast, insect and mammalian cells. Biotechnica 2007 Hannover, Germany
Auton KA, Bick JA, Taylor IM (2007 GEN 27:42
Kunas KT, Keating J (2005) Stirred tank-single-use bioreactor: comparison to traditional stirred tank bioreactor. bioLOGIC Europe, Geneva, Switzerland
Eibl R, Eibl D, Pechmann G, Ducommun C, Lisica L, Lisica S, Blum P, Schär M, Wolfram L, Rhiel M, Emmerling M, Röll M, Lettenbauer C, Rothmaier M, Flükiger M (2003) Produktion pharmazeutischer Wirkstoffe in disposable Systemen bis zum 100 L Massstab, Teil 1. KTI-Projekt 5844.2 FHS, Final Report, University of Applied Sciences Wädenswil, Switzerland, unpublished
Lisica S (2004) Energieeintrag in Wave-Bioreaktoren. Modelling approaches, University of Applied Sciences Wädenswil, Switzerland, unpublished
Nienow AW (2006) Cytotechnology 50:9
Martin I, Wendt D, Heberer M (2004) Trends Biotechnol 22:80
Altaras GM, Eklund C, Ranucci C, Maheswari G (2007) Biotechnol Bioeng 96:999
Jenke D (2007) J Pharm Sci 96:2566
Okonkowski J, Balasubramanian U, Seamans C, Fischrogen S, Zhang J, Lachs P, Robinson D, Chartrain M (2007) J Biosci Bioeng 103:50
van Tienhoven EAE, Korbee D, Schipper L, Verharen HW, Jong De WH (2006) J Biomed Mater Res A78:175
Pörtner R, Nagel-Heyer St, Goepfert C, Adamietz P, Meenen NM (2005) J Bioeng Biosci100:235
Ye H, Xia Z, Ferguson DJP, Triffitt JT, Cui Z (2007) J Mater Sci Mater Med 18:641
Cabrita GJM, Ferreira BS, da Silva CL, Goncales R, Almeida-Porada G, Cabral JMS (2003) Trends Biotechnol 21:233
Tzanakakis ES, Verfaillie CM (2006) Advances in adult stem cell culture. In: Ozturk SS, Hu WS (eds) Cell culture technology for pharmaceutical and cell-based therapies. CRC, New York, p 693
Carswell KS, Papoutsakis ET (2000) Biotechnol Bioeng 68:328
June CH, Ledbetter JA, Linsley PS, Thompson CB (1990) Immunol Today 11:211
Wurm FM (2004) Nat Biotechnol 22:1393
Wurm FM (2007) Novel technologies for rapid and low cost provisioning of antibodies and process details in mammalian cell culture based biomanufacturing. BioProduction 2007, Berlin, Germany
Schwander E, Rasmusen H (2005) GEN 25:29
DePalma A (2002) GEN 22:58
Vaughn J (1999) Insect cell culture, protein expression. In: Flickinger MC, Drew SW (eds) Encyclopedia of bioprocess technology, vol 3. Wiley, New York, p 1444
Weber W, Fussenegger M (2005) Baculovirus-based production of biopharmaceuticals using insect cell culture processes. In: Knäblein J (ed) Modern biopharmaceuticals. Wiley, Weinheim, p 1045
Durocher Y, Perret S, Kamen A (2002) Nucleic Acids Res 30:e9
Wurm FM, Bernard A (1999) Curr Opin Biotechnol 313:156
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2009 Springer-Verlag London
About this chapter
Cite this chapter
Eibl, R., Eibl, D. (2009). Application of Disposable Bag-Bioreactors in Tissue Engineering and for the Production of Therapeutic Agents . In: Advances in Biochemical Engineering / Biotechnology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/10_2008_23
Download citation
DOI: https://doi.org/10.1007/10_2008_23
Published:
Publisher Name: Springer, Berlin, Heidelberg